DRKS00028190招募中不适用
Oral Medicinal Cannabis (CBD:THC) as Add-On to Standard of Care for Symptomatic and Palliative Treatment in Cancer Patients - a Multicentre Prospective Patient Registry in Switzerland and Germany. - Swiss CanOn - Swiss Cannabis Oncology
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Written informed consent;
- •- Adult male and female patients > 18 years suffering from cancer related and/or chemotherapy or radiation therapy related symptoms;
- •- Patients who have not been previously treated with a medical cannabis product for cancer related and/or chemotherapy or radiation therapy related symptoms but now are scheduled for a treatment with cannabinoids;
- •- Using the consilium careTM App on their personal smartphone (Android or iOS system) as part of the routine medical data assessment;
- •- No cognitive impairment as judged by the treating physician;
- •- Ability to read and answer questions in German.
排除标准
- •Patients who are in the opinion of the investigator unsuitable for participation in the registry for any other reason not listed in the inclusion and exclusion criteria.
研究者
相似试验
已完成
2 期
A study that evaluates the effectiveness of oral medicinal cannabis for people with advanced cancer experiencing a range of symptoms.FatigueNauseaBreathlessnessAppetitePsychological effectsCancer - Any cancerCancerACTRN12618001220257Mater Misericordiae Limited144
已完成
2 期
A study that evaluates the effectiveness of oral combined THC/CBD for people with advanced cancer experiencing a range of symptoms.FatigueNauseaBreathlessnessAppetitePsychological effectsCancer - Any cancerCancerACTRN12619000037101Mater Misericordiae Limited144
已完成
1 期
Effect of oral herbal oil supplement (Cannabis Sativa L, Oenothera Biennis L) and advising diet with Hot nature on multiple sclerosis patientsMultiple Sclerosis.Demyelinating diseases of the central nervous systemIRCT138804252195N1eurosciences Research Center (NSRC)99
尚未招募
2 期
CBD/THC solution as a pharmacological strategy for patients with fibromyalgia (FibroCann)FibromyalgiaRBR-4bhmm7yFG Brasil LTDA
进行中（未招募）
不适用
Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-controlled, crossover study.Treatment of spasticity in patients with Multiple SclerosisMedDRA version: 9.1Level: LLTClassification code 10028245Term: Multiple sclerosisEUCTR2005-000393-47-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA